Overview

Update
Total Equity Funding
$57.7M in 4 Rounds from 5 Investors
Most Recent Funding
$10M Private Equity on June 16, 2015
Headquarters:
Lexington, MA
Description:
Pulmatrix develops inhaled therapies for the treatment, prevention and transmission of infectious and progressive respiratory diseases.
Founders:
,
Categories:
Pharmaceutical, Therapeutics, Biotechnology
Website:
http://www.pulmatrix.com
Social:

Company Details

Update

Pulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies for the treatment, prevention, and transmission control of infectious and progressive respiratory diseases. It offers inhaled cationic airway lining modulator drugs, which stimulate host defense mechanisms within the airway to treat and prevent influenza, rhinovirus, and chronic pulmonary diseases. The company was founded in 2003 and is based in Lexington, Massachusetts.

Funding Rounds (6) - $83.9M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jun, 2015$10M / Private Equity4
Feb, 2013$20.5M / Debt Financing0
Aug, 2011$14M / Series B4
Dec, 2010$5.7M / Grant0
Nov, 2009$30.2M / Series B4
Mar, 2009$3.5M / Series A2

Current Team (8)

Update

Offices/Locations (1)

Update
  • Office

    99 Hayden Avenue

    Suite 390

    Lexington, MA 02421

    USA

Past Team (3)

Update

Images (1)

Update

Add Acquisitions

Add Products

Add Sub Organizations

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos